Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
26.61
-0.01 (-0.04%)
At close: Oct 2, 2025, 4:00 PM EDT
26.61
0.00 (0.00%)
After-hours: Oct 2, 2025, 4:10 PM EDT
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 30, which predicts a 12.74% increase from the current stock price of 26.61.
Price Target: $30 (+12.74%)
Analyst Consensus: Sell
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for Fresenius Medical Care AG stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Sep 2, 2025 |
Truist Securities | Truist Securities | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | +12.74% | May 12, 2025 |
Truist Securities | Truist Securities | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | -6.05% | Jan 6, 2025 |
Truist Securities | Truist Securities | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | -13.57% | Oct 7, 2024 |
Truist Securities | Truist Securities | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | -17.32% | Jul 31, 2024 |
Financial Forecast
Revenue This Year
19.72B
from 19.34B
Increased by 2.01%
Revenue Next Year
20.34B
from 19.72B
Increased by 3.11%
EPS This Year
3.83
from 1.83
Increased by 109.14%
EPS Next Year
4.22
from 3.83
Increased by 10.32%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 20.9B | 21.8B | |||
Avg | 19.7B | 20.3B | |||
Low | 18.7B | 19.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.9% | 10.6% | |||
Avg | 2.0% | 3.1% | |||
Low | -3.5% | -2.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.27 | 4.86 | |||
Avg | 3.83 | 4.22 | |||
Low | 3.55 | 2.36 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 133.5% | 27.0% | |||
Avg | 109.1% | 10.3% | |||
Low | 93.9% | -38.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.